TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

for the International Working Group for MDS Molecular Prognostic Committee

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups'. Together they form a unique fingerprint.

Medicine & Life Sciences